| Title: |
Innovative Approach for the Prevention of Chemotherapy-Induced Peripheral Neuropathy in Cancer Patients: A Pilot Study With the Hilotherm Device, the Poliambulanza Hospital Experience |
| Authors: |
Oneda, Ester; Meriggi, Fausto; Zanotti, Laura; Zaina, Elisabetta; Bighè, Sara; Andreis, Federica; Rueda, Sabogal; Zaniboni, Alberto |
| Source: |
Integrative Cancer Therapies ; volume 19 ; ISSN 1534-7354 1552-695X |
| Publisher Information: |
SAGE Publications |
| Publication Year: |
2020 |
| Description: |
Background: Chemotherapy-induced peripheral neuropathy (CIPN) is an adverse event of taxanes, with no effective prevention or treatment available and a highly negative impact on patient quality of life. The aim of this study is to asses that the constant application of cooled cuffs on the hands and feet prevent and mitigate CIPN. Methods: Patients with breast, gynecologic, and pancreatic cancer who received weekly paclitaxel (PTX), PTX/carboplatin, and nab-paclitaxel (nab-PTX)/gemcitabine for any indication at the therapeutic scheduled dosage were included in this prospective study. Hilotherm Chemo care device forms a closed-loop system with cuffs and tubes through which a coolant flows at a temperature of 10 °C. CIPN was monitored using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (edition 3.0), and the tolerability and side effects were scored by using the Common Terminology Criteria for Adverse Events (T4.03 2017). Results: To date, we have enrolled 64 patients. Of these, 54 (84%) completed all cooling cycles. Continuous cooling was well tolerated by all patients. No patients had grade >2 CIPN or had serious or lasting adverse events as a result of Hilotherapy. The median time to CIPN onset was 77 days for the entire population. Conclusion: Hilotherapy has good effectiveness and tolerability and seems to be able to prevent or reduce the symptoms of CIPN. We are still recruiting patients to obtain more data and to collect data at 3 months after the end of chemotherapy. Prospective studies seem to be warranted. |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| DOI: |
10.1177/1534735420943287 |
| Availability: |
https://doi.org/10.1177/1534735420943287; https://journals.sagepub.com/doi/pdf/10.1177/1534735420943287; https://journals.sagepub.com/doi/full-xml/10.1177/1534735420943287 |
| Rights: |
https://creativecommons.org/licenses/by-nc/4.0/ |
| Accession Number: |
edsbas.6C3E619D |
| Database: |
BASE |